AI assistant
Sending…
CYTOKINETICS INC — Director's Dealing 2021
Feb 12, 2021
30870_dirs_2021-02-12_7062d9a7-5e2a-4ed9-873d-3b54b6af1876.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2021-02-11
Reporting Person: Malik Fady Ibraham (EVP Research & Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-11 | Common Stock | S | 1632 | $23.3438 | Disposed | 148809 | Direct |
Footnotes
F1: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020.
F2: Includes 1,470 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP).
More from CYTOKINETICS INC
Share Issue/Capital Change
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 27
Share Issue/Capital Change
2026
May 7
Report Publication Announcement
2026
May 5
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18